Related Experiment Videos
Antimicrobial resistance: is it really that bad?
1International Emerging Infections Program, US Centers for Disease Control and Prevention and Thai Ministry of Public Health, Building 7, Department of Disease Control, Ministry of Public Health, Tivanon Road, Nonthaburi, Thailand.
Seminars in Pediatric Infectious Diseases
|June 9, 2004
Summary
Antimicrobial resistance remains a substantial global threat, complicating pediatric infectious disease treatment and limiting therapeutic options. Despite some successful interventions, untreatable infections and rising costs persist, particularly in developing nations.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Stewardship
- Public Health
Background:
- Antimicrobial resistance (AMR) is a persistent global health concern, frequently discussed in pediatric and infectious disease literature.
- While some progress has been made in combating AMR, such as reduced unnecessary prescribing and new agent development, the problem remains substantial.
- Skepticism regarding dire predictions of untreatable infections exists, yet the reality of multiply resistant organisms and escalating treatment costs is undeniable.
Purpose of the Study:
- To highlight the ongoing and significant challenge of antimicrobial resistance in pediatric care.
- To underscore the impact of AMR on treatment options and costs for infectious diseases.
- To provide a balanced perspective on the successes and persistent challenges in addressing antimicrobial resistance.
Main Methods:
- Review of current literature and clinical observations regarding antimicrobial resistance in pediatric populations.
- Analysis of trends in prescribing practices, treatment modifications, and availability of new antimicrobial agents.
- Assessment of the economic and clinical impact of resistant organisms on patient care.
Main Results:
- Despite efforts to curb unnecessary antibiotic use and introduce new treatments, dangerous multiply resistant organisms continue to emerge.
- The costs associated with treating infections caused by resistant bacteria are escalating significantly.
- In many developing countries, antimicrobial resistance has rendered previously treatable infections untreatable, while in the US, it complicates routine pediatric practice.
Conclusions:
- Antimicrobial resistance continues to pose a serious threat to pediatric health worldwide, complicating treatment and limiting therapeutic choices.
- Effective strategies are needed to address the ongoing spread of resistance and its profound impact on patient outcomes and healthcare costs.
- Continued vigilance, research, and implementation of antimicrobial stewardship programs are crucial in managing this evolving public health crisis.